Found 222 matching trials
Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients PHASE2 The goal of this clinical research study is to learn if temozolomide alone ...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection PHASE3 This study was to assess whether sofosbuvir in combination with ribavirin (...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC PHASE1 The purpose of this study is to evaluate the combination of Pegylated Alfa ...
Show More Location
Baylor College of Medicine - Methodist Hospital
Learn More & Join Trial
Safety and Efficacy of Pegylated IFN-alpha 2B Added to Dasatinib in Newly Diagnosed Chronic Phase Myeloid Leukemia PHASE2 Patients with newly diagnosed CML have excellent outcomes with tyrosine kin...
Show More Location
Helsinki University Central Hospital
Learn More & Join Trial
Boceprevir Treatment in Liver Pre-transplant HCV Patients PHASE3 End-stage liver disease due to hepatitis C virus (HCV) is the most common i...
Show More Location
123, Ta Pei Road, Niao Sung Hsiang
Learn More & Join Trial
Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection PHASE3 Hepatitis C virus (HCV) infection is a leading cause of death and illness i...
Show More Learn More & Join Trial
Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype PHASE3 The purpose of this study is to evaluate if a 12-week total regimen of tela...
Show More Location
Multiple Locations
Learn More & Join Trial
Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin PHASE4 This is a 60-to-72 week multicenter study to evaluate Infergen and Ribaviri...
Show More Location
Atlantic Gastroenterology Associates
Learn More & Join Trial
Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) PHASE2 This study is intended to evaluate if 12 or 24 weeks of treatment with GSK3...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection PHASE2 Primary objectives:
The purpose of this study is to determine and compare ...
Show More Location
Changhua Christian Hospital
Learn More & Join Trial